The pharmacological properties of the novel peptide BPC 157 (PL-10)

Abstract

The reported beneficial effects of the gastric mucosal derived pentadecapeptide BPC 157 (Gly Glu Pro Pro Pro Gly Lys Pro Ala Asp Asp Ala Gly Leu Val, M.W. 1419) on different organ lesions are reviewed. Apart from the effects on various gastrointestinal lesions, the potentially beneficial effect on pancreas, liver injuries, endothelium and heart damage, i.e. dysrhythmias following reoxygenation, and blood pressure, along with effect on experimental acute/chronic inflammation, wound and fracture (pseudoarthrosis) healing are described. It appears that these beneficial effects all together provide a particular network reflecting activity of a special peptidergic defence system. In support of this concept, it appears that there are interactions of this pentadecapeptide with many important systems (namely, dopamine-, NO-, prostaglandin-, somatosensory neurone-systems), that could provide a basis for the observed protective effects. Moreover, since disturbance of these systems’ functions (i.e. dopamine-, NO-, somatosensory neuronal-system) which manifest either over-activity or as inhibition, may contribute to the multiple lesions in different organs. The reported evidence that this pentadecapeptide is able to counteract both their over-action, and their inhibition, may suggest this pentadecapeptide as a new, but most probably essential physiological defence system and that should be further investigated.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Thompson, J., Greeley, G. H. (Jr.), Rayford, P. L. and Townsed, C. M. (Jr.) (1987). Gastrointesti- nal Endocrinology. McGraw-Hill Book Company, New York.

    Google Scholar 

  2. 2.

    Sikiric, P., Petek, M., Rucman, R., etal. (1993). A new gastric juice peptide BPC — an overview of stomach/stress/organoprotection hypothesis and BPC beneficial effects, J. Physiol. (Paris) 87,313–327.

    Article  CAS  Google Scholar 

  3. 3.

    Sikiric, P., Gyires, K., Seiwerth, S., et al. (1993). The effect of pentadecapeptide BPC 157 on inflammatory, non-inflammatory, direct and indirect pain and capsaicin neurotoxicity, Inflammopharmacology 2, 121–127.

    Article  CAS  Google Scholar 

  4. 4.

    Sikiric, P., Banic, M., Brkic, T., et al. (1993). Effects of a novel pentadecapeptide BPC 157 and methylprednisolone in a murine model of inflammatory bowel disease, Gastroenterology 104, 782.

    Google Scholar 

  5. 5.

    Sikiric, P., Seiwerth, S., Grabarevic, Z., et al. (1993). Hepatoprotective effect of BPC 157, a 15-aminoacid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CCI4 application. A comparative study with dopamine agonists and somatostatin, Life Sci. 53, PL291-PL296.

    PubMed  Article  CAS  Google Scholar 

  6. 6.

    Sikiric, P., Seiwerth, S., Grabarevic, Z., et al. (1994). The beneficial effect of BPC 157, a 15 aminoacid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptides, Life Sci. 54, PL63-PL68.

    PubMed  Article  CAS  Google Scholar 

  7. 7.

    Sikiric, P., Rotkvic, I., Mise, S. et al. (1995). Dopamine agents efficacy in peptic ulcer healing and relapse prevention — a further indication for importance of stomach dopamine in the stress organoprotection concept, in: Neuroendocrinology of Gastrointestinal Ulceration: Hans Selye Symposia on Neuroendocrinology and Stress, Szabo, S., Taché, Y. and Glavin, G. (Eds), Vol. 2, pp. 221–230. Plenum, New York.

    Google Scholar 

  8. 8.

    Sikiric, P., Seiwerth, S., Grabarevic, Z., et al. (1996). Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats, Digestive Disease Sci. 41, 1518–1526.

    Article  CAS  Google Scholar 

  9. 9.

    Sikiric, P., Seiwerth, S., Grabarevic, Z., et al. (1996). The beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin and capsaicin neurotoxicity, Digestive Disease Sci. 41, 1604–1614.

    Article  CAS  Google Scholar 

  10. 10.

    Sikiric, P., Mazul, B., Seiwerth, S., et al. (1997). Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress, Digestive Disease Sci. 42, 661–671.

    Article  CAS  Google Scholar 

  11. 11.

    Sikiric, P., Mikus, D., Seiwerth, S., et al. (1997). Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine and atropine effect in cysteamine lesions in totally gastrectomized rats. A model study for cytoprotective studies, Digestive Disease Sci. 42, 1029–1037.

    Article  CAS  Google Scholar 

  12. 12.

    Sikiric, P., Seiwerth, S., Grabarevic, Z., et al. (1997). The influence of a novel pentadecapeptide BPC 157 on NG-nitro-L~arginine methylester and L-arginine effect on stomach mucosal integrity and blood pressure, European J. Pharmacol. 332, 23–33.

    Article  Google Scholar 

  13. 13.

    Grabarevic, Z., Tisljar, M., Artukovic, B., et al. (1997). The influence of BPC 157 on nitric oxide agonists and antagonist induced lesions in broiler chicks, J. Physiol. (Paris) 91, 139–150.

    Article  CAS  Google Scholar 

  14. 14.

    Seiwerth, S., Sikiric, P., Grabarevic, Z., et al. (1997). BPC 157 effect on healing, J. Physiol. (Paris) 91, 173–178.

    Article  CAS  Google Scholar 

  15. 15.

    Jelovac, N., Sikiric, P., Rucman, R., et al. (1998). A novel pentadecapeptide BPC 157 blocks the stereotypy produced acutely by amphetamine and the developement of haloperidol-induced supersensitivity to amphetamine, Biol. Psych. 43, 511–519.

    Article  CAS  Google Scholar 

  16. 16.

    Konjevoda, P., Nasic, M., Curkovic, T, Sikiric, P., Seiwerth, S. and Stambuk, N. (1998). Effects of BPC 157 on the healing of corneal lesions, in: Uveitis Today, Ohno, S., Aoki, K., Usui, M. and Uchio, E. (Eds), pp. 311–314. Elsevier, Amsterdam.

    Google Scholar 

  17. 17.

    Kalogjera, L., Ries, N., Baudoin, T., Ferencic, Z., Protic, R. and Pegan, B. (1997). Dose dependent protective effect of BPC 157 in capasaicin induced rhinitis in rats, European Arch. Otorhinolaryngol. 254, S9-S11.

    Article  Google Scholar 

  18. 18.

    Sikiric, P., Seiwerth, S., Grabarevic, Z., et al. (1997). Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agents-induced gastrointestinal lesions and adjuvant arthritis in rats, J. Physiol. (Paris) 91, 113–122.

    Article  CAS  Google Scholar 

  19. 19.

    Sikiric, P., Seiwerth, S., Deskovic, S. et al. (1999). New model of cytoprotection/adaptive cytoprotection in rats: endogenous small irritants, antiulcer agents and indomethacin, European J. Pharmacol. 364,23–31.

    Article  CAS  Google Scholar 

  20. 20.

    Sebecic, B., Nikolic, V., Sikiric, P. et al. (1999). Osteogenic effect of a gastric pentadecapeptide BPC 157, on the healing of segmental bone defect in rabbits. A comparison with bone marrow and autologous cortical bone implantation, Bone 24, 195–202.

    PubMed  Article  CAS  Google Scholar 

  21. 21.

    Zoricic, I., Sikiric, P., Seiwerth, S., et al. (1997). Pentadecapeptide BPC 157 beneficially influences the healing of colon-colon anastomoses in rats, in: Cell Injury and Protection in the Gastrointestinal Tract. From basic sciences to clinical perspectives 1996, Mozsik, Gy., Nagy, L., Par, A. and Rainsford, K. D. (Eds), pp. 249–258. Kluwer Academic Publishers, Dordrecht.

    Google Scholar 

  22. 22.

    Sikiric, P., Seiwerth, S., Grabarevic, Z., et al. (1997). The effect of pentadecapeptide BPC 157, H2 blockers and sucralfate on new vessels and new granulation tissue formation, Gastroenterology 112,291.

    Google Scholar 

  23. 23.

    Sikiric, P., Jadrijevic, S., Seiwerth, S., et al. (1997). Pentadecapeptide BPC 157 reduces esophagojejunal anastomosis-esophageal ulceration in rats, Gastroenterology 112, 219.

    Google Scholar 

  24. 24.

    Bodis, B., Karadi, O., Nagy, L., et al. (1997). Direct cellular effects of some mediators, hormones and growth factor-like agents on denervated (isolated) rat gastric mucosal cells, J. Physiol. (Paris) 91, 183–187.

    Article  CAS  Google Scholar 

  25. 25.

    Bodis, B., Karadi, O., Nagy, L., et al. (1997). Evidence for direct cellular protective effect of PL-10 substances (synthesized parts of body protection compound BPC) and their specificity to gastric mucosal cells, Life Sci. 61, PL 243-PL 248.

    Article  CAS  Google Scholar 

  26. 26.

    Veljaca, M., Pllana, R., Lesch, C. A., Sanchez, B., Chan, K. and Guglietta, A. (1994). Protective effect of BPC 157 on a rat model of colitis, Gastroenterology 106, 789.

    Google Scholar 

  27. 27.

    Veljaca, M., Lech, C. A., Pllana, R., Sanchez, B., Chan, K. and Guglietta, A. (1994). BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats, J. Pharmacol. Exp. Ther. 272,417–422.

    Google Scholar 

  28. 28.

    Veljaca, M, Chan, K. and Guglietta, A. (1995). Digestion of h-EGF, h-TGF α, and BPC 15 in human gastric juice, Gastroenterology 108, 761.

    Article  Google Scholar 

  29. 29.

    Veljaca, M., Lesch, C. A., Sanchez, B., Low, J. and Guglietta, A. (1995). Protection of BPC-15 on TNBS-induced colitis in rats: possible mechanisms of action, Gastroenterology 108, 936.

    Google Scholar 

  30. 30.

    Bosnjak, Z. J., Graf, B. M. and Sikiric, P. (1994). Protective effects of newly isolated gastric peptide following hypoxic and reoxygenation injury in the isolated guinea pig heart, FASEB J. 8, A 129.

    Google Scholar 

  31. 31.

    Sandor, Z., Vincze, A. and Szabo, S. (1996). The protective effect of a recently isolated gastric peptide in acute and chronic gastroduodenal injury, FASEB J. 10, 171.

    Google Scholar 

  32. 32.

    Sandor, Z., Vincze, A., Jadus, M. R., et al. (1997). The protective effect of newly isolated peptide PL-10 in the iodoacetamide colitis model in rats, Gastroenterology 112, 400.

    Google Scholar 

  33. 33.

    Paré, W. and Kluczynski, J. M. (1994). The effect of new gastric juice peptide BPC on classic stress triad in stress procedure, Exp. Clin. Gastroenterol. 2, 234–236.

    Google Scholar 

  34. 34.

    Erceg, D., Simicevic, V. N., Kolega, M. and Dohoczky, C. (1997). Some aspects of PL-10.1.AK- 15 on the gastrointestinal tract, J. Physiol. (Paris) 91, 179–181.

    Article  CAS  Google Scholar 

  35. 35.

    Szabo, S. and Glavin, G. B. (1990). Hans Selye and the concept of biologic stress. Ulcer pathogenesis as a historical paradigm, Ann. N. Y Acad. Sci. 597, 14–16.

    PubMed  Article  CAS  Google Scholar 

  36. 36.

    Selye, H. (1936). A syndrome produced by diverse noxious agents, Nature 138, 32.

    Google Scholar 

  37. 37.

    Robert, A. (1979). Cytoprotection by prostaglandins, Gastroenterology 77, 761–767.

    PubMed  CAS  Google Scholar 

  38. 38.

    Moneada, S., Palmer, R. M. J. and Higgs, E. A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol. Rev. 43, 109–142.

    Google Scholar 

  39. 39.

    Whittle, B. J. R., Boughton-Smith, N. K. and Moneada, S. (1992). Biosynthesis and role of the endothelium-derived vasodilator, nitric oxide in gastric mucosa, Ann. N. Y Acad. Sci. 664, 126–139.

    PubMed  Article  CAS  Google Scholar 

  40. 40.

    Holzer, P. (1991). Peptidergic sensory neurons in the control of vascular functions: Mechanisms and significance in the cutaneous and splanchnic vascular beds, Rev. Physiol. Biochem. Pharmacol. 121,49–146.

    Article  Google Scholar 

  41. 41.

    Szabo, S., Trier, T. S., Brown, A. and Schnoor, J. (1985). Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat, Gastroenterology 88, 228–236.

    PubMed  CAS  Google Scholar 

  42. 42.

    Szabo, S. and Usadel, K. H. (1982). Cytoprotection-organoprotection by somatostatin: gastric and hepatic lesions, Experientia. 38, 254–256.

    PubMed  Article  CAS  Google Scholar 

  43. 43.

    Szabo, S. (1986). Experimental basis for a role for sulfhydryls and dopamine in ulcerogenesis: a primer for cytoprotection-organoprotection, Klin-Wochenschr. 64 (suppl. 7), 116–122.

    PubMed  CAS  Google Scholar 

  44. 44.

    Geokas, M. C, Baltaxe, H. A., Banks, P. A., Silva, J. and Frey, C. F. (1985). Acute pancreatitis, Ann. Int. Med. 103, 86–100.

    PubMed  CAS  Google Scholar 

  45. 45.

    Par, A. (1992). Free radical mechanisms in gastrointestinal and liver diseases. A review, Exp. Clin. Gastroenterol. 2, 162–173.

    CAS  Google Scholar 

  46. 46.

    Slater, T. F., Cheeseman, K. H., Davies, M. J., Proudfoot, K. and Sharma, O. P. (1985). Mechanisms of protection against free-radical-mediated liver cell injury, in: Free radicals in liver injury, Slater, T. F., Cheeseman, K. H. and Davies, M. J. (Eds), pp. 197–205. IRL Press, Oxford, Washington.

    Google Scholar 

  47. 47.

    Damas, J. and Deflandre, E. (1984). The mechanism of anti-inflammatory effect of turpentine in the rat, Naunyn-Schmiedeberg’s Arch. Pharmacol. 327, 143–147.

    Article  CAS  Google Scholar 

  48. 48.

    Willoughby, S. G., Hopps, R. M. and Johnson, N. W. (1986). Changes in the epithelial proliferation of rat or oral mucosa in response to acute inflammation induced by turpentine, Archs Oral Biol. 31, 193–199.

    Article  CAS  Google Scholar 

  49. 49.

    Winter, C. A., Risley, E. A. and Nuss, G. W. (1962). Carrageenin-induced oedema in hind paw of the rat as an assay for antiinflammatory drugs, Proc. Soc. Exp. Biol. Med. 111, 544–547.

    PubMed  CAS  Google Scholar 

  50. 50.

    Gyires, K., Furst, S., Miklya, I., Budavari, I. and Knoll, J. (1985). Analysis of the analgetic and anti-inflammatory effects or rimazolium, a pyrimido-pyrimidine derivate, compared with that of prostaglandin synthesis inhibitors and morphine, Drugs Exptl Clin. Res. 11, 495–500.

    Google Scholar 

  51. 51.

    Brkic, T., Banic, M., Anic, B., Grabarevic, Z., Rotkvic, I., Artukovic, B., Duvnjak, M., Sikiric, P., Troskot, B., Hernandez, D. E. (1992). A model of inflammatory bowel disease induced by 2,4-dinitrofluorbenzene in previously sensitized BALB-c mice, Scand. J. Gastroenterol. 27, 184–188.

    PubMed  CAS  Google Scholar 

  52. 52.

    Klagsburn, M. and Folkman, J. (1991). Angiogenesis, in: Peptide Growth Factors and their Receptors II, Sporn, M. B. and Roberts, A. B. (Eds), pp. 549–586. Springer-Verlag, New York.

    Google Scholar 

  53. 53.

    Klinge, B., Lehto-Axtelius, D., Akerman, M. and Hakanson, R. (1985). Structure of calvaria after gastrectomy. An experimental study in the rat, Scand. J. Gastroenterol. 30, 952–957.

    Google Scholar 

  54. 54.

    Kobayashi, S., Takahashi, C., Kuroda, T., Sugenoya, A., Iida, F. and Katoh, K. (1994). Calcium regulating hormones and bone mineral content in patients after subtotal gastrectomy, Surg Today. 24, 295–298.

    PubMed  Article  CAS  Google Scholar 

  55. 55.

    Masuda, Y., Murai, S., Saito, H., et al. (1991). The enhancement of the hypomotility induced by small doses of haloperidol in the phase of dopaminergic supersensitivity in mice, Neuropharma- cology 30, 35–40.

    CAS  Article  Google Scholar 

  56. 56.

    Adams, J. D. and Odunze, I. N. (1991). Commentary. Biochemical mechanisms of l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity, Biochem. Pharmacol. 41, 1099–1105.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Predrag Sikiric MD, PhD.

Additional information

This work under the direction of Prof. Sikiric involved the following authors: Gorana Aralica, Josip Aralica, Gojko Buljat, Valentina Coric, Vedran Coric, Bozidar Duplancic, Miroslav Gjurasin, Zeljko Grabarevic, Miroslav Hanzevacki, Stipislav Jadrijevic, Vjekoslav Jagic, Pasko Konjevoda, Martina Lovric, Anton Marovic, Pavle Miklic, Darko Mikus, Stjepan Mise, Darko Perovic, Marijan Petek, Ivo Rotkvic, Rudolf Rucman, Bozidar Sebecic, Sven Seiwerth, Jadranka Separovic, Zoran Simec, Zoran Slobodnjak, Dinko Stancic-Rokotov, Branko Turkovic, Tomislav Ziger, Ivan Zoricic.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sikiric, P. The pharmacological properties of the novel peptide BPC 157 (PL-10). Inflammopharmacol 7, 1–14 (1999). https://doi.org/10.1007/s10787-999-0022-z

Download citation

Key words:

  • BPC 157 (PL-10)
  • gastrointestinal lesions
  • acute pancreatitis
  • liver lesions
  • inflammation and pain
  • heart
  • blood pressure
  • behaviour
  • physiological defence system